文献速递产科母胎医学

B型利钠肽在妊娠期诊断心力衰竭中的敏感性和特异性

Sensitivity and Specificity of B-Type Natriuretic Peptide in Diagnosing Heart Failure in Pregnancy.
PubMed 文献 · Obstet Gynecol · 2019-01-01

本研究为回顾性诊断准确性研究,纳入2007至2018年在一家产科教学医院行B型利钠肽和超声心动图检查的单胎妊娠或产后妇女,由两名心血管疾病专家共识判定心力衰竭。39例(65%)诊断为心力衰竭,B型利钠肽最佳阈值为111 pg/mL(95% CI 78-291),敏感性95%(95% CI 83-99),特异性62%(95% CI 38-82)。

要点

  • 疑似心力衰竭孕妇及产后妇女中,B型利钠肽中位数在心衰组为326 pg/mL,无心衰组为75.5 pg/mL(P<.01)。
  • 最佳阈值111 pg/mL时,B型利钠肽诊断心衰敏感性95%(95% CI 83-99),特异性62%(95% CI 38-82)。
  • B型利钠肽是评估妊娠及产后疑似心力衰竭妇女的有用临床工具。

核心结论

  • B型利钠肽是评估妊娠及产后疑似心力衰竭妇女的有用临床工具。

研究设计与样本

  • 回顾性诊断准确性研究,纳入2007至2018年在一家产科教学医院行B型利钠肽和超声心动图检查的单胎妊娠及产后妇女。
  • 排除已知心脏病或多胎妊娠者,由两名对B型利钠肽值盲的心血管疾病专家共识判定心力衰竭,分歧由第三名专家裁决。

主要发现

  • 共纳入22例孕妇和38例产后妇女,平均年龄32±6.8岁。
  • 疑似心力衰竭就诊时常见临床特征包括子痫前期(33/60,55%)、呼吸困难(50/60,83%)、胸部不适(34/60,58%)和双下肢水肿(32/60,53%)。
  • 39例(65%)妇女诊断为心力衰竭。
  • 心力衰竭组B型利钠肽中位数为326 pg/mL(四分位距200.5-390.5),无心衰组为75.5 pg/mL(四分位距19-245),P<.01。
  • 估计最佳B型利钠肽阈值为111 pg/mL(95% CI 78-291),该阈值下45例(75%)妇女B型利钠肽升高,诊断心力衰竭敏感性95%(95% CI 83-99)、特异性62%(95% CI 38-82)、阳性似然比2.5(95% CI 1.4-4.3)、阴性似然比0.1(95% CI 0.0-0.3)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of B-type natriuretic peptide as a diagnostic tool for heart failure in pregnant or postpartum women with singleton gestations. METHODS: We conducted a retrospective study of diagnostic accuracy. We identified pregnant and postpartum women with B-type natriuretic peptide and echocardiography performed at an obstetric teaching hospital from 2007 to 2018. Women with known cardiac disease or multiple gestation were excluded. A panel of two cardiovascular disease experts, blinded to B-type natriuretic peptide values, determined the diagnosis of heart failure by consensus. Their judgement was based on detailed clinical features and parameters at the time of presentation with suspected heart failure. Where consensus could not be reached, differences were adjudicated by a third expert. A receiver operating characteristic curve estimated the sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of B-type natriuretic peptide at various thresholds. RESULTS: In total, 22 pregnant and 38 postpartum women were included in the cohort. Average age was 32±6.8 years. The most common clinical features at the time of presentation with suspected heart failure included preeclampsia (33/60, 55%), dyspnea (50/60, 83%), chest discomfort (34/60, 58%), and bilateral lower extremity edema (32/60, 53%). In total, 39 (65%) women had heart failure. The median B-type natriuretic peptide level was 326 pg/mL (interquartile range 200.5-390.5) in women with heart failure, as compared with 75.5 pg/mL (interquartile range 19-245) in women without heart failure (P<.01). The estimated optimal B-type natriuretic peptide cutoff was 111 (95% CI 78-291) pg/mL. Using this threshold, 45 (75%) women had an elevated B-type natriuretic peptide, which yielded a 95% sensitivity (95% CI 83-99), 62% specificity (95% CI 38-82), a positive likelihood ratio of 2.5 (95% CI 1.4-4.3), and a negative likelihood ratio of 0.1 (95% CI 0.0-0.3) for heart failure. CONCLUSIONS: B-type natriuretic peptide is a useful clinical tool to evaluate pregnant and postpartum women with suspected heart failure.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Malhamé I, Hurlburt H, Larson L, et al. Sensitivity and Specificity of B-Type Natriuretic Peptide in Diagnosing Heart Failure in Pregnancy. Obstet Gynecol. 2019. PMID: 31403607. doi:10.1097/AOG.0000000000003419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。